HORIZON-JU-GH-EDCTP3-2024-01-04-two-stage
HORIZON-JU-GH-EDCTP3-2024-01-04-two-stage
Programme: Horizon Europe
5 projects · €27,808,182 total EU contribution (project-level) · 54 participating organizations · 27 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€27,808,182
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (6)
- NG (5)
- US (4)
- ZA (4)
- CH (3)
- ET (3)
- UK (3)
- BE (2)
- CA (2)
- Italy (2)
- KE (2)
- MZ (2)
- Netherlands (2)
- BJ (1)
- CI (1)
- Spain (1)
- GH (1)
- GW (1)
- KR (1)
- MD (1)
- MW (1)
- NO (1)
- PT (1)
- RW (1)
- SE (1)
- SZ (1)
- UG (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- LMU KLINIKUM2 projects · DE
- LMU MUENCHEN2 projects · DE
- UNIVERSITY COLLEGE LONDON2 projects · UK
- UCT2 projects · ZA
- UU2 projects · SE
- ARSI UNIVERSITY1 projects · ET
- BAYLOR COLLEGE OF MEDICINE CHILDRENS FOUNDATION ESWATINI1 projects · SZ
- CEMTROD1 projects · NG
- LRM1 projects · BJ
- CITY1 projects · UK
- CSRS1 projects · CH
- FONDAZIONE PENTA ETS1 projects · IT
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Risk stratified care to reduce antibiotic use and AMR transmission in African hospitals PediSEP1 · 101190839 | HORIZON | €5,998,993 | €514,360 | Details |
Combating Multidrug-Resistant Gram-Negative Bacteria in Africa through Diagnostic and Antimicrobial Stewardship ComBac-Africa · 101190791 | HORIZON | €5,869,999 | €2,575,000 | Details |
Antimicrobial Stewardship, Prevention of Infection and Resistance in Africa ASPIRE · 101190733 | HORIZON | €2,840,208 | €100,138 | Details |
Tuberculosis Antimicrobial Stewardship Program (TASP): tackling Bedaquiline-resistant tuberculosis TASP · 101190782 | HORIZON | €5,999,991 | €1,555,182 | Details |
EX-DR TB: Elimination of Extensive Drug Resistance Through better Regimens for TB EX-DR TB · 101190913 | HORIZON | €7,098,991 | €257,330 | Details |